Neochem Bio IPO: Price, GMP, Analysis, And Details

Neochem Bio IPO- Company Analysis 

Neochem Bio IPO under the SME IPO category is a book build issue of Rs. 44.97 Cr by Neochem Bio Ltd. and is involved in the production of specialist performance chemicals. Textile and clothing washing, home and personal care (HPC), institutional and industrial cleansers, water treatment, paints and coatings, paper and pulp, construction, rubber, dyes, and pigments are just a few of the industries that employ the company's vital goods.

The company provides a wide range of textile and clothing washing auxiliaries that are compatible with different processing machinery, including pre-treatment, dyeing, finishing, printing, and coating applications across all fabric and clothing substrates.

Neochem Bio IPO Details

The Neochem Bio IPO date of opening is 02 December 2025, its initial public offering will end on 04 Dec, IPO allotment on Dec 05 and refund initiation on Dec 08, 2025.

The Rs. 44.97 crore new SME IPO comprises a wholly fresh issue of 0.46 crore shares.

The Neochem Bio IPO listing date (expected) might be on Tuesday, Dec 09, 2025, and listing at the NSE and SME. 

The Neochem Bio IPO price band is Rs. 93 to Rs. 98.

IPO Timetable (Tentative)

Events	Date
IPO Opening Date	Dec 02, 2025
IPO Closing Date	Dec 04, 2025
IPO Allotment Date	Dec 05, 2025
Refund Initiation	Dec 08, 2025
IPO Listing Date	Dec 09, 2025

 

Click to open demat account and apply for the IPO.

 

 

Company Financials

(Amount in Cr)

Particulars	31 Mar 2025	31 Mar 2024	31 Mar 2023
Assets	78.89	64.06	50.60
Total Income	86.15	62.01	48.79
Profit After Tax (PAT)	7.75	1.80	1.07
EBITDA	13.11	5.99	4.23
Net Worth	19.75	12.00	8.05
Reserves & Surplus	13.08	5.33	2.63
Total Borrowing	35.62	33.32	26.24

 

Cash Flows

(Amount in lac)

Net Cash Flow	31 Mar 2025	31 Mar 2024	31 Mar 2023
Net Cash Flow Operating Activities	259.47	196.42	(74.18)
Net Cash Flow Investing Activities	(168.67)	(785.84)	(335.08)
Net Cash Flow Financing Activities	(120.41)	619.91	375.71

Revenue Bifurcation

(Rs. in Lac)

(Source: RHP)

The Objective of the Issue

The company desires to use the Net Proceeds from the Issue to fulfill its following goals:

• Funding the long-term working capital requirements of the Company. ~ Rs. 23.90 Cr.

• Repayment/prepayment, in full or part, of all or certain outstanding borrowings availed by the Company. ~ Rs. 10 Cr.

• General corporate purposes. 

Listed Peers of Neochem Bio Ltd.

Company Name	Face Value (Rs. )	EPS (Rs. )	P/E Ratio (x)
Rossari Biotech Ltd.	2	24.66	26.00
Indian Emulsifiers Ltd.	10	11.40	8.83

 

Valuation

KPI	Values
ROE	48.82%
ROCE	41.67%
Debt-to-Equity	1.80
RoNW	48.82%
PAT Margin	9.00%
EBITDA Margin	15.58%
Price to Book Value	5.80

 

 

Evaluation of P/E Ratio

Considering the period ended on FY 2025 with an EPS of Rs. 6.64 from the last year, the resulting P/E ratio is 14.75x.

Explore the Mother Nutri IPO.

IPO's Strengths

• Increasing the presence in all end-user application sectors

• Dedication to the ongoing creation of sustainable solutions and novel performance chemistries.

• Maintaining the emphasis on growing geographically.

• Diversify end-user industries by utilizing current strategic alliances and collaborations.
  
  

IPO’s Weaknesses 

• A few significant client accounts for a sizable portion of Neochem's earnings.

• There are no long-term supply agreements with the company.  Short-term purchase orders, which clients can change or cancel at any time, account for the majority of sales.

• Orders from customers may be canceled, reduced, or delayed.

• Neochem produces tailored, specialized chemicals for a variety of industries; therefore, abrupt shifts in consumer demand may result in surplus inventory, underutilized capacity, and financial loss.

• Insufficient use of installed capacity.

Neochem Bio IPO GMP (Grey Market Premium)

Neochem Bio IPO GMP today is Rs. 9 as of 01 Dec 2025 at the time of writing this information.

Neochem Bio IPO Summary

IPO Opening & Closing Date	02 Dec, 2025 to 04 Dec, 2025
Face Value	Rs. 10 per Share
Issue Price	Rs. 93 to Rs. 98  per Share.
Lot Size	1200 Shares
Issue Size	45,88,800 Shares (Rs. 44.97 Cr)
Offer for Sale	-
Fresh Issue	45,88,800 Shares (Rs. 44.97 Cr)
Listing at	NSE, SME
Issue Type	Book build issue IPO
Registrar	MUFG Intime India Pvt. Ltd.

IPO Lot Details 

Retail investors can invest in a minimum of 2 Lots (2400 Shares) for Rs. 2,35,200, and in multiples thereof, while S-HNI investors can invest in a minimum of 3 Lots (3600 Shares) for Rs. 3,52,800.

Minimum Lot Investment (Retail)	2 Lots
Maximum Lot Investment (Retail)	2 Lots
S-HNI (Min)	3 Lots

 

Neochem Bio IPO Allotment Status

To check the Neochem Bio IPO Allotment Status, visit the official Registrar’s website or BSE website. Below are the website links for you.

Using BSE Website - ​BSE IPO allotment status

Promoters And Management of Neochem Bio Ltd.

• Swapnil Rameshbhai Makati

• Hemangini Swapnil Dathia.

Pre-Issue Promoter Shareholding	91.12%
Post-Issue Promoter Shareholding	66.7%

 

IPO Lead Managers

• Vivro Financial Services Pvt. Ltd.
  
  

Dividend Policy

The company has not declared a dividend during the last three financial years.

 

 

Conclusion

Strong growth visibility is provided by Neochem Bio's IPO, which is supported by growing revenues, large margins, and expansion into several end-user industries. However, the lack of long-term contracts and reliance on a small number of important clients present significant concerns. After assessing prices and SME-market volatility, investors looking to gain exposure to niche specialty chemicals should give it some thought.

 

Finowings IPO Analysis

Hope you enjoyed the Finowings IPO Analysis. We tried our best to give every required detail about the company that you should know before applying to the IPO. 

You must consult your financial advisor before making any financial decisions. 

To Apply for the IPO, Click Here.

To Read the Prospectus of the Company Click Here to Download the DRHP.

Click Here To Stay Updated With The Upcoming IPOs.

DISCLAIMER: This blog is NOT any buy or sell recommendation. No investment or trading advice is given. The content is purely for educational and information purposes only. Always consult your eligible financial advisor for investment-related decisions.